Cardiorenal syndrome : mechanisms, risk, and treatment /
Saved in:
Imprint: | Milan : Springer, c2010. |
---|---|
Description: | 1 online resource (xv, 396 p.) : ill. |
Language: | English |
Subject: | |
Format: | E-Resource Book |
URL for this record: | http://pi.lib.uchicago.edu/1001/cat/bib/8895543 |
Table of Contents:
- Links between chronic kidney disease and cardiovascular disease: a bidirectional relationship
- Cardiorenal versus renocardiac syndrome
- Non-pressure-related deleterious effects of excessive dietary sodium
- Regulation of vascular and renal cells by common mediators in health and disease: role of the renin-angiotensin system in the pathophysiology of hypertension and cardiovascular disease
- Cardiorenal continuum
- Definition and classification of stages of chronic kidney disease: screening for chronic kidney disease
- Cardiovascular disease risk factors in chronic kidney disease: traditional, nontraditional and uremia-related threats
- Increased levels of urinary albumin: a cardiovascular risk factor and a target for treatment
- Microalbuminuria and kidney disease: an evidence-based perspective
- Cardiometabolic syndrome
- Diabetes mellitus: is the presence of nephropathy important as a cardiovascular risk factor for cardioneral syndrome?
- Cardiovascular disease: coronary artery disease and coronary artery calcification
- Cardiomyopathy in chronic kidney disease and in end-stage renal disease
- Pathophysiological mechanisms and prognostic significance of renal functional impairment in cardiac patients
- Stroke
- Uremic toxins
- Endothelial dysfunction, nitric oxide bioavailability, and asymmetric dimethyl arginine
- Pathophysiologic link between artherosclerosis and nephrosclerosis
- Aortic stiffness, kidney disease, and renal transplantation
- Disturbed calcium-phosphorus metabolism/arterial calcifications: consequences on cardiovascular function and clinical outcome
- Role of neurohormonal activation in the pathogenesis of cardiovascular complications in chronic kidney disease
- Impaired autonomic blood pressure and blood volume control in chronic renal failure
- Role of novel biomarkers in chronic kidney disease: urotensin II
- Role of novel biomarkers in chronic kidney disease: renalase
- Diabetic kidney disease
- Nondiabetic kidney disease
- Approaches in the management of patients with chronic kidney disease and cardiovascular disease
- Trends in the management of cardiac patients with renal functional impairment.